Document Detail


The role of fibrinolytics in the prehospital treatment of ST-elevation myocardial infarction (STEMI).
MedLine Citation:
PMID:  18164167     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The efficacy of fibrinolytics in the treatment of ST-elevation myocardial infarction is directly related to the time of administration, with the first 2 h after symptom onset seen as a critical period for greatest improvement in cardiovascular parameters and mortality. The American College of Cardiology/American Heart Association recommends a medical contact to treatment time of 30 min for fibrinolysis in patients with ST-elevation myocardial infarction. In selected patients, reperfusion goals may be expedited with prehospital administration of fibrinolytics. In clinical trials, prehospital fibrinolysis markedly reduced the time from symptom onset to treatment, allowed earlier ST-segment resolution, and reduced short- and long-term mortality compared with in-hospital treatment. Prehospital fibrinolysis has become more feasible with the introduction of prehospital 12-lead electrocardiography, improved skills of emergency medical services personnel, improved communication with the Emergency Department, and the advent of bolus fibrinolysis. Rapid and accurate administration of a fibrinolytic is vital for the success of prehospital fibrinolysis.
Authors:
Assaad J Sayah; Matthew T Roe
Related Documents :
22280797 - Pacemaker-mediated tachycardia initiated by an atrioventricular search algorithm to min...
16226097 - Designing prehospital ecg systems for acute coronary syndromes. lessons learned from cl...
10545677 - Role of myocardial ischemia and left ventricular wall motion abnormalities as contribut...
17587737 - Mechanism and new findings in brugada syndrome.
20160247 - Peripartum heart failure caused by left ventricular diastolic dysfunction.
2299487 - Coronary arteriosclerosis in pediatric heart transplant survivors: limitation of long-t...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review     Date:  2007-12-27
Journal Detail:
Title:  The Journal of emergency medicine     Volume:  34     ISSN:  0736-4679     ISO Abbreviation:  J Emerg Med     Publication Date:  2008 May 
Date Detail:
Created Date:  2008-05-05     Completed Date:  2008-06-26     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8412174     Medline TA:  J Emerg Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  405-16     Citation Subset:  IM    
Affiliation:
Cambridge Health Alliance, Harvard Medical School, Cambridge, Massachusetts, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angioplasty, Transluminal, Percutaneous Coronary
Emergency Medical Services / methods*,  statistics & numerical data
Evidence-Based Medicine
Fibrinolytic Agents / therapeutic use*
Humans
Myocardial Infarction / drug therapy*,  mortality,  therapy
Time Factors
Treatment Outcome
Chemical
Reg. No./Substance:
0/Fibrinolytic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Emergency Medicine Residents and Statistics: What is the Confidence?
Next Document:  Framing effect debiasing in medical decision making.